TLR9 and Parkinson disease: It was also hypothesized that a reduced glucocorticoid receptor activity in PD due to chronically high cortisol levels could lead to TLR9 activation by components released by dopaminergic neurons, which could, in turn, exacerbate the death of these cells (Maatouk et al., 2018).